Glycosite-deleted mRNA of SARS-CoV-2 spike protein as a broad-spectrum vaccine
Chung‐Yi Wu, Cheng‐Wei Cheng, Chih‐Chuan Kung, Kuo‐Shiang Liao, Jia‐Tsrong Jan, Che Ma, Chi‐Huey Wong
Abstract
Significance To contain the spread of SARS-CoV-2, the mRNA vaccine of viral spike protein has proven to be highly effective, although the efficacy against the emerging variants is decreasing. Here, we show that the mRNA of spike protein with deletion of glycosites in the RBD or especially the S2 domain to expose more conserved epitopes can be used as a broadly protective vaccine against the wild type and variants of concern. The spike protein translated from such mRNA was not properly folded, and thus induced cell apoptosis and a strong T cell response. Our findings demonstrate the importance of the glycosylation effect on the development of broadly protective mRNA vaccines.